November 10, 2024
Advance Stroke Drug Development through ADME/DMPK Study
Ace Therapeutics, one of the leading preclinical CRO companies for stroke, is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. Drug metabolism and pharmacokinetics (DMPK) play a crucial role in the drug development process for stroke. DMPK studies involve the evaluation of how…
marinabarrow